Eversept Partners’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.68M Buy
+515,804
New +$5.55M 0.4% 58
2026
Q1
Sell
-145,431
Closed -$1.64M 123
2025
Q4
$1.64M Buy
+145,431
New +$1.8M 0.08% 90
2024
Q4
Sell
-132,537
Closed -$6.62M 70
2024
Q3
$6.62M Buy
+132,537
New +$5.16M 0.45% 33
2024
Q1
Sell
-66,898
Closed -$2.86M 72
2023
Q4
$2.86M Sell
66,898
-64,205
-49% -$2M 0.25% 46
2023
Q3
$3.41M Hold
131,103
0.29% 54
2023
Q2
$3.14M Sell
131,103
-54,492
-29% -$938K 0.26% 52
2023
Q1
$2.54M Hold
185,595
0.18% 46
2022
Q4
$2.58M Buy
+185,595
New +$2.62M 0.23% 47

Other funds holding BHVN

Eversept Partners's BHVN Position: Q2 2026 in Review

Eversept Partners opened a new position in Biohaven (BHVN) in Q2 2026: 515,804 shares worth $7.68M. The stake represents 0.4% of the portfolio and ranks #58 among its holdings. This is a return to the name: Eversept Partners previously reported a position in BHVN as recently as Q4 2025.

Eversept Partners first reported a position in BHVN in Q4 2022 and has held it in 8 quarters since. 294 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Eversept Partners held 515,804 shares of Biohaven worth $7.68M as of Q2 2026.
  • Biohaven was a new Eversept Partners position in Q2 2026.
  • Biohaven made up 0.4% of Eversept Partners's portfolio in Q2 2026, its #58 holding.
  • Eversept Partners first reported a position in Biohaven in Q4 2022 and has held it in 8 quarters since.
  • 294 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.